Erica Pimenta, MD, PhD, discusses her research into using existing GLP-1 receptor agonists in dedifferentiated liposarcoma.
Erica Pimenta, MD, PhD
Erica Pimenta, MD, PhD, is an instructor at Harvard Medical School and physician-scientist at Dana-Farber Cancer Institute
Articles by Erica Pimenta, MD, PhD
Erica Pimenta, MD, PhD, discusses how the IGF-1 and GLP-1 pathways could potentially be targets in dedifferentiated liposarcoma.
Erica Pimenta, MD, PhD, discussed the goals and key findings from her and her colleagues’ research into IGF-1 and GLP-1 signaling pathways in liposarcoma.
Latest Updated Articles
Can GLP-1 Agonists Help Treat Rare Cancers?March 5th 2026